- Home
- HKD vs ANNX Comparison
HKD vs ANNX Comparison
Compare HKD & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- ANNX
- Stock Information
- Founded
- HKD 2003
- ANNX 2011
- Country
- HKD France
- ANNX United States
- Employees
- HKD N/A
- ANNX N/A
- Industry
- HKD Finance: Consumer Services
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- HKD Finance
- ANNX Health Care
- Exchange
- HKD Nasdaq
- ANNX Nasdaq
- Market Cap
- HKD 595.6M
- ANNX 540.4M
- IPO Year
- HKD 2022
- ANNX 2020
- Fundamental
- Price
- HKD $2.65
- ANNX $5.26
- Analyst Decision
- HKD
- ANNX Strong Buy
- Analyst Count
- HKD 0
- ANNX 7
- Target Price
- HKD N/A
- ANNX $15.80
- AVG Volume (30 Days)
- HKD 301.9K
- ANNX 1.5M
- Earning Date
- HKD 01-01-0001
- ANNX 11-14-2024
- Dividend Yield
- HKD N/A
- ANNX N/A
- EPS Growth
- HKD N/A
- ANNX N/A
- EPS
- HKD 0.33
- ANNX N/A
- Revenue
- HKD $27,776,448.00
- ANNX N/A
- Revenue This Year
- HKD N/A
- ANNX N/A
- Revenue Next Year
- HKD N/A
- ANNX N/A
- P/E Ratio
- HKD $8.10
- ANNX N/A
- Revenue Growth
- HKD N/A
- ANNX N/A
- 52 Week Low
- HKD $2.57
- ANNX $3.27
- 52 Week High
- HKD $5.80
- ANNX $8.40
- Technical
- Relative Strength Index (RSI)
- HKD 33.86
- ANNX 45.80
- Support Level
- HKD $2.58
- ANNX $4.69
- Resistance Level
- HKD $2.87
- ANNX $5.23
- Average True Range (ATR)
- HKD 0.17
- ANNX 0.33
- MACD
- HKD -0.03
- ANNX 0.10
- Stochastic Oscillator
- HKD 6.73
- ANNX 68.14
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. The company integrates various digital businesses using its AMTD SpiderNet ecosystem. Its reportable segments are; digital solutions services financial services; digital solutions services non-financial services, hotel operations, hospitality and VIP services, digital media, content and marketing services, and others. The company generates maximum revenue by providing financial digital solutions through its AMTD Risk Solutions, a digital insurance brokerage platform, and PolicyPal which is a digital insurance technology platform. Geographically, the company generates maximum revenue from Hong Kong and the rest from Canada and Singapore.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.